Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03933631Phase 3Recruiting
Phase 3, randomised trial of pilocarpine in Glaucoma and ocular hypertension (2 arms), sponsored by Montefiore Medical Center. Primary endpoint: Percentage of patients with lowering of intraocular pressure at 1 year. Started May 2019; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03933631.